朱大岭，博士，博士研究生导师，哈尔滨医科大学 (大庆)校长。首批“龙江学者”特聘教授，黑龙江省生物医药工程重点实验室——省部共建国家重点实验室培育基地副主任；美国Wisconsin医学院客座教授；哈尔滨医科大学学报主编；国家和黑龙江省政府特殊津贴专家；黑龙江省领导直接联系专家；“863”课题评审专家；国家自然科学基金委员会生命科学部，生理学与整合生物学专家评审组成员；Cancer Investigation，Apoptosis等著名国际学术期刊审稿人；是国际有影响、国内知名的肺血管研究领域科学家。主要从事肺高血压发病机制及早期诊断和治疗靶点的确定，基因工程药物和重大疾病早期诊断试剂盒研制研究，首先发现了15-LO/15-HETE在调节缺氧性肺动脉高压中的作用及其机制。承担和完成科研项目32项，获批项目资助经费1000余万元。发表论文160余篇，其中国外学术期刊发表SCI收录文章74篇，影响因子合计超过220。
Dr.Zhu Daling was exceptionally promoted to professor and doctoral tutor in Harbin Medical University in 1995. He is one of the first “Longjiang Scholar” distinguished professors, president of School of Pharmacy of Harbin Medical University, the associate director of Heilongjiang Key Laboratory of Biomedical Engineering-Cultivation Base of State Key Laboratory built together with Heilongjiang Province, a visiting professor of Medical College of Wisconsin. Dr. Zhu Daling was the founding member of the state and Heilongjiang province special government allowance; he possesses good contacts with leaders of Heilongjiang Province. And also the reviewer of some famous international magazines such as Cancer Investigation, Apoptosis,international Journal for Biotechnologyand Molecular Biology Research.Dr. Zhu Daling focus on the research of pulmonary artery hypertension and early diagosis kits for some serious diseases, and he is the holder of several research grants and accomplished 32 research projects, including five general programs from the National Natural Science Foundation of China, two of foreign exchange and cooperation projects of National Natural Science Foundation of China, three sub-projects of “863” project and one from National Key Technology Research and Development Program of China-China Human Liver Proteome Project sub-project. He has also contributed to three patents for national invention. He has won the second prize for two projects and won the third prizes for three projects at Heilongjiang Provincial National Science. Dr. Zhu Daling has published over 170 academic journals in both national and international, of which 74 have been collected by SCI. Thus making the total impact factor is220.
Sun shiqin ,Ph.D, Professor, Master Instructor, Dean of College of Pharmacy. A professional committee member of the Traditional Chinese medicine resources ecology and Clinical Drug Evaluation of Heilongjiang Province Pharmaceutical Association. A member of Heilongjiang Province pharmacological and cell biological institutes. A managing director of Daqing pharmacological association. Used to be a visiting scholar of Vladivostok State University Medical School, Hong Kong University Li Jiacheng Medical School and Harvard Medical School. She has been focusing on the anti-inflammatory immune activity of traditional Chinese medicine to discover new drugs by utilizing traditional Chinese medicine resources. 9 of 23 papers were indexed by SCI in recent years. Editing the Chinese Medicine Resources (deputy editor), Ecological studies of traditional Chinese medicine resources (complier editor) and the third edition amendments to the National Chinese herbal medicine (complier editor). Conducted 2 projects from NIH and DOD in US and "significant new drugs creation" in China etc. Won a national Chinese Bureau of Science and Technology Progress Award (second prize), Daqing City scientific and technological achievements Award (third prize), Harbin Medical University Teaching Achievement Award (first prize), A national invention patent, The honorary title of Harbin Medical University "women's model", Harbin Medical University (Daqing) first top ten teachers.
Peng Haisheng , Associate Professor, the Postdoctoral Master Instructor School of Pharmacy Party secretary, a member of the Institute of Heilongjiang Province pharmacological, Chinese neuroscience member, a member of the Association China Branch of the slow-release, the National Natural Science Foundation Committee evaluation experts. Harbin Medical University, received his Ph.D. in 2008, is mainly engaged in the slow-release, controlled-release drug delivery system drug loading MBP peptide-induced the neural immune tolerance research. In September 2008, Harbin Medical University post-doctoral programs work, to carry out the ischemic myocardium targeted sustained release drug delivery system. Papers 22 core journals were published in the past few years, SCI included 15 first author (Corresponding author) 10. Was one of the Heilongjiang Province Natural Science Academic Achievement Award in 2009 second prize (first prize); senate histological techniques use teaching materials a School of Pharmaceutical Sciences, Peking University, March 2010-August for further study, worked in 2009 The year 2010 HMU outstanding teachers, outstanding party members and the new Long March torchbearers title.
Yu,Lei,Ph.D., Associate Dean of College of Pharmacy. Dr. Yu’s research is focused on the mechanism of vascular tone regulation with ion channels and pathomechanism of pulmonary artery hypertension. Over 10 research papers have being published on the SCI journals. Holder of 2 provincial foundations.
Li Sen ,Professor,Associate Dean of College of Pharmacy and Director of Department of Chemistry.Professor Li is a member of the Chinese Chemical Engineering Association. She is also a member of the National Natural Science Foundation Committee as well as a member of the Education Ministry Scientific Research Fund and Technology Awards, and her role is to participate in the evaluation of research projects received by these committees. Her research focuses on the molecular design of new drugs, and their syntheses and pharmacological activities. She also conducts research on slow-release drug carrier. Over the past few years, her research group has published 20 papers in peer-viewed journals, and 7 of these are SCI-publications. She has received awards from the municipal and provincial governments for her scientific achievement. She has also received first prizes from the 22nd and 23rd Daqing Natural Science Academic Achievement Awards, second prize from the 24th Daqing Natural Science Academic Achievement Awards, and third prize from the 12th Natural Science Academic Achievement Award of Heilongjiang Province. In addition, she has also received an honorary title of First Top Ten Teachers from JiXi City (Heilongjiang). She has edited 7 textbooks, and she mainly teaches physical chemistry and polymer science at the undergraduate level.
白玉华，教授，硕士研究生导师，在读博士，天然药物化学教研室主任；留日归国学者，美国化学会会员，国家自然科学基金评审专家，教育部科研基金及科技奖励评审专家。1991年毕业于佳木斯医学院化学制药专业； 2005年留学日本新潟大学，从事天然药物化学研究； 2007年获齐齐哈尔大学分析化学专业硕士学位；2012年攻读哈尔滨医科大学药物化学博士学位。主要承担中药化学、天然药物化学及有机化合物波谱解析等课程的教学工作，主要科研方向为天然药物活性成分及中药药理学研究。主持参加国家自然基金委与日本科学振兴机构联合资助项目1项、 黑龙江省自然科学基金（留学归国人员与及海外合作）项目1项、黑龙江省高等教育学会“十二五”教育科学研究规划课题1项近几年发表SCI收录文章15篇（其中2篇收编于国际论著）；编写教材2部；建设精品课程1门。获大庆市第二十二届自然科学技术学术成果三等奖1项，第二十三届自然科学技术学术成果二等奖1项，第二十四届自然科学技术学术成果一等奖1项，黑龙江省第十二届自然科学技术学术成果奖三等奖1项；获大庆市三八红旗手、哈尔滨医科大学巾帼模范称号、哈尔滨医科大学优秀教研室主任、优秀教师等荣誉称号。
Bai Yuhua , Professor, Supervisor of Masters，Evaluation expert of the National Natural Science Foundation Committee, Evaluation expert of the Education Ministry Scientific Research Fund and Technology Awards , member of ACS (American Chemistry Society). B.Sc. pharmaceutics, Jiamusi Medical University,1991; M.Sc. Niigata University, Japan, 2005; M.Sc. analytical chemistry, Qiqihaer University, 2007; Ph.D candidate, medicinal chemistry, Harbin Medical University, 2012. She currently takes in charge of the department of Natural Medicinal Chemistry, Her research work is focused on the bioactive constituents of TCM (Traditional Chinese Medicine) / Natural Medicinal Products , and the pharmaceutical effects of new compounds isolated from TCM. 25 papers were published in peer-viewed journals in the past few years, 14 of them were SCI included , her achievements were awarded by the municipal and provincial government respectively, she won the 22d, 23rd, 24th Daqing Natural Science Academic Achievement Award, 12d Natural Science Academic Achievement Award of Heilongjiang province , and several titles of honor（ advanced teacher, outstanding director and “March 8” Hongqi Shou etc.
Wei Taiming, Ph.D., one member of Communist Party of China. Associate Professor, super tutor. He completed his Ph.D. work at Beijing University of Chinese Medicine, and now he takeAssociates the deputy director of Biopharmaceutical Institute of the Heilongjiang Academy of Medical Sciences. His major work is the study of pharmacognosy active ingredients in medicinal chemistry. He acts as the expert of doctoral funds of the ministry of education of Heilongjiang, and one expert of the National Natural Science Foundation Committee of China, as well as one judge of natural funds of Heilongjiang province and Beijing. Besides, he is the guest reviewer of China J Chin Mater Med.He got many key projects from the Science and Technology Commission of China and Shanghai and had rich experience in scientific research and production. Now he is the chair of the research subject the preclinical studies of XL analgesic capsule. He has already published 11 papers in CSSCI, obtained 1 patent, won the third prize of medicine and health in Heilongjiang, and participated in the writing of 3 books. He is mainly engaged in the research of Cycloartane from Commiphora Myrrh and the effect and its mechanisms on human prostatic cancer PC-3 and DU145 cells. He got the honors of sanyuren and outstanding teacher of Harbin medical university.